Tapewire

Nasdaq · USD

ANAB

ANAPTYSBIO, INC

Export transactions ↓
Tapewire entity
4640
SEC CIK
0001370053
Parsed reports
295

Last 12 months

Inside the activity.

0 purchase rows · 42 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 2025010
Jan 2026017
Feb 202601
Mar 2026013
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 02, 2025 Filed Jul 3, 2025 17:34 UTC Exercise / conversionCommon Stock 20,925 $6.93 $145,010.25
Disclosure

SEC source: 0001415889-25-019242 · form4-07032025_050730.xml · nonDerivative · entry 1

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,890

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 20:07 UTC SaleCommon Stock 3,015 $23.97 $72,269.55
Disclosure

SEC source: 0001415889-25-017820 · form4-06202025_080627.xml · nonDerivative · entry 1

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,965

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2024.

F2 · shares: Shares sold to satisfy a portion of the tax obligation in connection with the vesting of restricted stock units on June 15, 2025.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 20:06 UTC SaleCommon Stock 3,015 $23.97 $72,269.55
Disclosure

SEC source: 0001415889-25-017819 · form4-06202025_080641.xml · nonDerivative · entry 1

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,965

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024.

F2 · shares: Shares sold to satisfy a portion of the tax obligation in connection with the vesting of restricted stock units on June 15, 2025.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:29 UTC Exercise / conversionRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017586 · form4-06172025_100608.xml · derivative · entry 2

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,030 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:29 UTC Exercise / conversionCommon Stock 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017586 · form4-06172025_100608.xml · nonDerivative · entry 1

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,530

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:30 UTC Exercise / conversionRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017587 · form4-06172025_100656.xml · derivative · entry 3

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,030 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:30 UTC Exercise / conversionCommon Stock 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017587 · form4-06172025_100656.xml · nonDerivative · entry 1

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:31 UTC
Orwin John ADirector
Exercise / conversionRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017589 · form4-06172025_100627.xml · derivative · entry 2

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,030 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:31 UTC
Orwin John ADirector
Exercise / conversionCommon Stock 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017589 · form4-06172025_100627.xml · nonDerivative · entry 1

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:33 UTC Exercise / conversionRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017591 · form4-06172025_100602.xml · derivative · entry 2

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,030 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:33 UTC Exercise / conversionCommon Stock 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017591 · form4-06172025_100602.xml · nonDerivative · entry 1

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:30 UTC Exercise / conversionRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017588 · form4-06172025_100644.xml · derivative · entry 2

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,030 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:30 UTC Exercise / conversionCommon Stock 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017588 · form4-06172025_100644.xml · nonDerivative · entry 1

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:33 UTC
Jain RitaDirector
Exercise / conversionRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017592 · form4-06172025_100645.xml · derivative · entry 3

Jain Rita · CIK 0001707797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,030 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:33 UTC
Jain RitaDirector
Exercise / conversionRestricted Stock Unit · Derivative 1,300 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017592 · form4-06172025_100645.xml · derivative · entry 2

Jain Rita · CIK 0001707797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,300

Underlying: Common Stock · 1,300 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date.

F2 · derivative.expiration_date: The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:33 UTC
Jain RitaDirector
Exercise / conversionCommon Stock 7,330 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017592 · form4-06172025_100645.xml · nonDerivative · entry 1

Jain Rita · CIK 0001707797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,864

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:32 UTC Exercise / conversionRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017590 · form4-06172025_100617.xml · derivative · entry 2

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,030 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F2 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 22:32 UTC Exercise / conversionCommon Stock 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017590 · form4-06172025_100617.xml · nonDerivative · entry 1

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,930

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
March 25, 2025 Filed Mar 27, 2025 20:10 UTC OtherCommon Stock 11,068 $18.18 $201,240.59
Disclosure

SEC source: 0001415889-25-009100 · form4-03272025_080308.xml · nonDerivative · entry 1

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By ESOP

Disclosed balance after: 11,068

F1 · kind: Shares purchased under the SpeakInc. Employee Ownership Plan ("Plan") of which the Reporting Person is a trustee of the Plan.

F2 · ownership.direct: The reported shares are held by the Plan of which the Reporting Person is a trustee of the Plan. The Reporting Person has less than 1% of a pecuniary interest in the Plan and disclaims beneficial ownership of these shares to the amount in excess of such Report Person's pecuniary interest.

Read SEC document
January 13, 2025 Filed Jan 15, 2025 22:04 UTC Exercise / conversionStock Option (right to buy) · Derivative 20,645 $0.00 Strike: $8.54 $0.00
Disclosure

SEC source: 0001415889-25-001501 · form4-01152025_100107.xml · derivative · entry 4

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,645 shares

Expires 2025-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested.

Read SEC document
January 13, 2025 Filed Jan 15, 2025 22:04 UTC Exercise / conversionStock Option (right to buy) · Derivative 21,692 $0.00 Strike: $4.55 $0.00
Disclosure

SEC source: 0001415889-25-001501 · form4-01152025_100107.xml · derivative · entry 3

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,692 shares

Expires 2025-06-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested.

Read SEC document
January 13, 2025 Filed Jan 15, 2025 22:04 UTC Exercise / conversionCommon Stock 20,645 $8.54 $176,308.30
Disclosure

SEC source: 0001415889-25-001501 · form4-01152025_100107.xml · nonDerivative · entry 2

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,237

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercises reported on this Form 4 for various stock options are expiring in 2025 and the Reporting Person wished to facilitate the exercises of such options before their expiration. The Reporting Person does not intend to currently sell any of the said exercised shares in this Form 4.

Read SEC document
January 13, 2025 Filed Jan 15, 2025 22:04 UTC Exercise / conversionCommon Stock 21,692 $4.55 $98,698.60
Disclosure

SEC source: 0001415889-25-001501 · form4-01152025_100107.xml · nonDerivative · entry 1

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercises reported on this Form 4 for various stock options are expiring in 2025 and the Reporting Person wished to facilitate the exercises of such options before their expiration. The Reporting Person does not intend to currently sell any of the said exercised shares in this Form 4.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:28 UTC GrantRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001035 · form4-01072025_100157.xml · derivative · entry 2

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:28 UTC GrantStock Option (right to buy) · Derivative 16,510 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001035 · form4-01072025_100157.xml · derivative · entry 1

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,510

Underlying: Common Stock · 16,510 shares

Expires 2035-01-06

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 7, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:33 UTC
Lizzul Paul F.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 97,200 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001046 · form4-01072025_100117.xml · derivative · entry 8

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,200

Underlying: Common Stock · 97,200 shares

Expires 2035-01-06

F8 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:33 UTC
Lizzul Paul F.Chief Medical Officer
GrantRestricted Stock Unit · Derivative 34,100 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001046 · form4-01072025_100117.xml · derivative · entry 7

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,100

Underlying: Common Stock · 34,100 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F7 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F7 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:27 UTC
Faga DanielDirector · President, CEO
GrantStock Option (right to buy) · Derivative 305,500 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001034 · form4-01072025_100123.xml · derivative · entry 8

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,500

Underlying: Common Stock · 305,500 shares

Expires 2035-01-06

F8 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:27 UTC
Faga DanielDirector · President, CEO
GrantRestricted Stock Unit · Derivative 107,350 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001034 · form4-01072025_100123.xml · derivative · entry 7

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,350

Underlying: Common Stock · 107,350 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F7 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F7 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:28 UTC GrantRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001036 · form4-01072025_100120.xml · derivative · entry 2

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:28 UTC GrantStock Option (right to buy) · Derivative 16,510 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001036 · form4-01072025_100120.xml · derivative · entry 1

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,510

Underlying: Common Stock · 16,510 shares

Expires 2035-01-06

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 7, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:29 UTC
Orwin John ADirector
GrantRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001038 · form4-01072025_100134.xml · derivative · entry 2

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:29 UTC
Orwin John ADirector
GrantStock Option (right to buy) · Derivative 16,510 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001038 · form4-01072025_100134.xml · derivative · entry 1

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,510

Underlying: Common Stock · 16,510 shares

Expires 2035-01-06

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 7, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 17:32 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
GrantStock Option (right to buy) · Derivative 67,000 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001042 · form4-01072025_100105.xml · derivative · entry 8

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,000

Underlying: Common Stock · 67,000 shares

Expires 2035-01-06

F8 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 17:32 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
GrantRestricted Stock Unit · Derivative 23,550 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001042 · form4-01072025_100105.xml · derivative · entry 7

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,550

Underlying: Common Stock · 23,550 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F7 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F7 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:31 UTC GrantRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001041 · form4-01072025_100131.xml · derivative · entry 2

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:31 UTC GrantStock Option (right to buy) · Derivative 16,510 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001041 · form4-01072025_100131.xml · derivative · entry 1

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,510

Underlying: Common Stock · 16,510 shares

Expires 2035-01-06

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 7, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:29 UTC GrantRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001037 · form4-01072025_100100.xml · derivative · entry 2

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:29 UTC GrantStock Option (right to buy) · Derivative 16,510 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001037 · form4-01072025_100100.xml · derivative · entry 1

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,510

Underlying: Common Stock · 16,510 shares

Expires 2035-01-06

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 7, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:32 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
GrantStock Option (right to buy) · Derivative 76,400 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001044 · form4-01072025_100138.xml · derivative · entry 8

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,400

Underlying: Common Stock · 76,400 shares

Expires 2035-01-06

F8 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:32 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
GrantRestricted Stock Unit · Derivative 26,800 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001044 · form4-01072025_100138.xml · derivative · entry 7

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,800

Underlying: Common Stock · 26,800 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F7 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F7 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:30 UTC
Jain RitaDirector
GrantRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001040 · form4-01072025_100153.xml · derivative · entry 2

Jain Rita · CIK 0001707797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:30 UTC
Jain RitaDirector
GrantStock Option (right to buy) · Derivative 16,510 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001040 · form4-01072025_100153.xml · derivative · entry 1

Jain Rita · CIK 0001707797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,510

Underlying: Common Stock · 16,510 shares

Expires 2035-01-06

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 7, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:30 UTC GrantRestricted Stock Unit · Derivative 6,030 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001039 · form4-01072025_100114.xml · derivative · entry 2

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,030

Underlying: Common Stock · 6,030 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2025 Filed Jan 7, 2025 22:30 UTC GrantStock Option (right to buy) · Derivative 16,510 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001415889-25-001039 · form4-01072025_100114.xml · derivative · entry 1

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,510

Underlying: Common Stock · 16,510 shares

Expires 2035-01-06

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 7, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:33 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 6,145 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001046 · form4-01072025_100117.xml · derivative · entry 6

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,290

Underlying: Common Stock · 6,145 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F6 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F6 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:33 UTC
Lizzul Paul F.Chief Medical Officer
Tax withholdingCommon Stock 2,261 $15.30 $34,593.30
Disclosure

SEC source: 0001415889-25-001046 · form4-01072025_100117.xml · nonDerivative · entry 4

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,643

F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.

F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:33 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon Stock 6,145 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001046 · form4-01072025_100117.xml · nonDerivative · entry 3

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,904

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:27 UTC
Faga DanielDirector · President, CEO
Exercise / conversionRestricted Stock Unit · Derivative 17,850 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001034 · form4-01072025_100123.xml · derivative · entry 6

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,700

Underlying: Common Stock · 17,850 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F6 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F6 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:27 UTC
Faga DanielDirector · President, CEO
Tax withholdingCommon Stock 6,387 $15.30 $97,721.10
Disclosure

SEC source: 0001415889-25-001034 · form4-01072025_100123.xml · nonDerivative · entry 4

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 436,466

F3 · shares: Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.

F4 · shares: The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.